Stress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients
The Effect of Stress Ball on Anxiety, Fear and Vital Signs in Patients With Gastrointestinal System Cancer
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will investigate whether using a stress ball during chemotherapy can reduce anxiety, fear, and changes in vital signs in patients with gastrointestinal system cancers. Patients receiving chemotherapy for gastrointestinal cancers often experience anxiety and fear, which may affect their heart rate, blood pressure, and breathing. A stress ball is a simple, low-cost, and safe method that may help patients relax during treatment. In this randomized controlled study, 60 patients receiving chemotherapy will be assigned to either a stress ball group or a routine care group. Patients in the stress ball group will squeeze a stress ball for 15 minutes during their chemotherapy session. Anxiety, fear levels, and vital signs will be measured before and after chemotherapy in both groups. The results of this study may help determine whether stress ball use is an effective non-drug method to improve emotional well-being and physiological stability in patients undergoing chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedStudy Start
First participant enrolled
February 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 3, 2027
February 11, 2026
February 1, 2026
1 year
January 19, 2026
February 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
State Anxiety (STAI-State) score
Baseline (before chemotherapy session) and immediately after chemotherapy session
Secondary Outcomes (7)
Fear Severity (VAS-Fear)
Baseline (before chemotherapy session) and immediately after chemotherapy session
Systolic Blood Pressure
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Diastolic Blood Pressure
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Heart Rate (Pulse)
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.
Respiratory Rate
Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session
- +2 more secondary outcomes
Study Arms (2)
Stress Ball Intervention
EXPERIMENTALParticipants in this arm will receive routine chemotherapy care and will additionally perform stress ball squeezing for 15 minutes starting at the beginning of the chemotherapy session. Patients will be instructed to inhale while squeezing the ball and exhale while releasing it, focusing attention on the activity.
Routine Care Control
NO INTERVENTIONParticipants in this arm will receive routine chemotherapy care during their chemotherapy session and will not perform any stress ball or additional relaxation intervention.
Interventions
The intervention consists of guided stress ball squeezing during chemotherapy. A round, medium-firm, compressible stress ball approximately 5-6 cm in diameter will be provided to participants. Starting at the beginning of the chemotherapy session, participants will squeeze the stress ball continuously for 15 minutes. They will be instructed to inhale while squeezing the ball, exhale while releasing their grip, and focus their attention on the squeezing activity. Disposable gloves will be used to maintain hygiene during the intervention. No additional behavioral or pharmacological interventions will be applied.
Eligibility Criteria
You may qualify if:
- Being aged 18 years or older
- Having a diagnosis of gastrointestinal system cancer and receiving chemotherapy
- Having no communication problems
- Having no physical disability that would prevent squeezing a stress ball
- Willingness to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Artvin State Hospital
Artvin, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- The Effect of Stress Ball on Anxiety, Fear, and Vital Signs in Patients With Gastrointestinal System Cancer
Study Record Dates
First Submitted
January 19, 2026
First Posted
February 3, 2026
Study Start
February 3, 2026
Primary Completion (Estimated)
February 3, 2027
Study Completion (Estimated)
February 3, 2027
Last Updated
February 11, 2026
Record last verified: 2026-02